Frontlight ResearchEarly access
Trial site
E-Da Cancer Hospital
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Bladder cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Coherus Oncology, Inc.2 trials
- Academia Sinica, Taiwan1 trial
- Anbogen Therapeutics, Inc.1 trial
- Inhibrx Biosciences, Inc1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026